Podcasts about genome sequencing

In this eye-opening episode of The Joe Cohen Show, Joe sits down with microbiologist and biotech entrepreneur Kiran Krishnan to dismantle the myths and marketing hype surrounding microbiome testing. Drawing parallels between the DNA and microbiome industries, they expose the scientific shortcuts, technological flaws, and misleading health claims being sold to consumers.Krishnan, the mind behind one of the few microbiome platforms used in published research, breaks down what a legitimate test looks like and why most tests on the market fall short, sometimes by as much as 70% in accuracy. The conversation also explores probiotics in depth, why strain specificity matters, and how consumers can make more informed decisions when navigating this complex and evolving space.Whether you're a health professional or someone trying to optimize your gut, this episode will help you separate science from sales.

Nathan explores the cutting-edge intersection of AI and rare disease research with Dr. Catherine Brownstein of Boston Children's Hospital and Harvard Medical School. In this episode of The Cognitive Revolution, we dive into how frontier AI models are revolutionizing the diagnosis of rare diseases. Join us for an insightful conversation with a ChatGPT Pro grant winner who's pioneering the use of AI to help patients find answers faster. Help shape our show by taking our quick listener survey at https://bit.ly/TurpentinePulse Check out Modern Relationships, where Erik Torenberg interviews tech power couples and leading thinkers to explore how ambitious people actually make partnerships work. This season's guests include: Delian Asparouhov & Nadia Asparouhova, Kristen Berman & Phil Levin, Rob Henderson, and Liv Boeree & Igor Kurganov. Apple: https://podcasts.apple.com/us/podcast/id1786227593 Spotify: https://open.spotify.com/show/5hJzs0gDg6lRT6r10mdpVg YouTube: https://www.youtube.com/@ModernRelationshipsPod SPONSORS: Oracle Cloud Infrastructure (OCI): Oracle's next-generation cloud platform delivers blazing-fast AI and ML performance with 50% less for compute and 80% less for outbound networking compared to other cloud providers. OCI powers industry leaders like Vodafone and Thomson Reuters with secure infrastructure and application development capabilities. New U.S. customers can get their cloud bill cut in half by switching to OCI before March 31, 2024 at https://oracle.com/cognitive NetSuite: Over 41,000 businesses trust NetSuite by Oracle, the #1 cloud ERP, to future-proof their operations. With a unified platform for accounting, financial management, inventory, and HR, NetSuite provides real-time insights and forecasting to help you make quick, informed decisions. Whether you're earning millions or hundreds of millions, NetSuite empowers you to tackle challenges and seize opportunities. Download the free CFO's guide to AI and machine learning at https://netsuite.com/cognitive Shopify: Dreaming of starting your own business? Shopify makes it easier than ever. With customizable templates, shoppable social media posts, and their new AI sidekick, Shopify Magic, you can focus on creating great products while delegating the rest. Manage everything from shipping to payments in one place. Start your journey with a $1/month trial at https://shopify.com/cognitive and turn your 2025 dreams into reality. Vanta: Vanta simplifies security and compliance for businesses of all sizes. Automate compliance across 35+ frameworks like SOC 2 and ISO 27001, streamline security workflows, and complete questionnaires up to 5x faster. Trusted by over 9,000 companies, Vanta helps you manage risk and prove security in real time. Get $1,000 off at https://vanta.com/revolution CHAPTERS: (00:00:00) Teaser (00:00:56) About the Episode (00:04:45) Rare Diseases Common (00:06:48) Patient Journey (00:12:57) Genome Sequencing (00:19:39) Sponsors: Oracle Cloud Infrastructure (OCI) | NetSuite (00:22:19) Diagnosis Process (00:30:50) Data Pipelines (00:35:51) Sponsors: Shopify | Vanta (00:39:07) Interaction Graphs (00:42:18) Data Accessibility (00:43:42) AI in Pipelines (00:45:40) LLM Impact (00:48:40) Anomaly Detection (00:52:07) Data Sharing (00:58:49) Data Reform (01:02:41) AI's Potential (01:04:30) AI Applications (01:06:57) Prompt Engineering (01:14:51) Model Comparison (01:19:16) Prompting Insights (01:22:14) Move 37 Analogy (01:24:34) Future Potential (01:29:27) Future Experience (01:32:39) Outro SOCIAL LINKS: Website: https://www.cognitiverevolution.ai Twitter (Podcast): https://x.com/cogrev_podcast Twitter (Nathan): https://x.com/labenz LinkedIn: https://www.linkedin.com/in/nathanlabenz/ Youtube: https://www.youtube.com/@CognitiveRevolutionPodcast Apple: https://podcasts.apple.com/de/podcast/the-cognitive-revolution-ai-builders-researchers-and/id1669813431 Spotify: https://open.spotify.com/show/6yHyok3M3BjqzR0VB5MSyk

Ever wondered if we could read the ultimate book of life? Genome sequencing makes it possible!

This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science entrepreneur, discussing his extensive experience in commercialization, mergers, and acquisitions. Russ shares invaluable insights on the importance of marketing, fundraising strategies for biotech startups, the phases of taking a company from idea to commercialization, and the critical steps toward securing regulatory approvals. We also touch on the intersection of genome sequencing, blockchain, and AI, exploring how this convergence is set to democratize and capitalize on personal DNA. Whether you're new to biotech or an industry veteran, this episode offers a wealth of knowledge and practical advice on navigating the complex landscape of life sciences and startups.Get Russ's recommended book! Freakonomics: A Rogue Economist Explores the Hidden Side of EverythingLearn more about LifeSci Catalyst Partners!Connect with Russ on LinkedIn!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction and Early Aspirations02:04 Journey into Medical Sales03:37 Marketing and Commercialization Insights05:31 Navigating Early-Stage Startups08:39 Fundraising Strategies for Biotech Startups15:00 Acquisitions and Exits22:39 The Intersection of Genome Sequencing, Blockchain, and AI29:49 Future Goals and Recommendations31:47 Closing Remarks and Contact Information

In this episode, we connect with Dr. Mikolaj Raszek, the Founder and Managing Director of Merogenomics. As a consistent scientific thinker, Dr. Raszek is an expert in the field of genome sequencing. In 2014, he decided to start a business centering around this fascinating technology and hasn't looked back since…  The purpose of Merogenomics is to provide the general public with access to medical DNA testing. The results of these tests enable individuals to seek proper medical intervention for an array of conditions – all while giving them an inside look at their inner biology.  Join the discussion now to explore: The four groups that individuals fall into.  The medical value that DNA tests can provide.  What genome sequencing shows about the metabolization of medicine.  Why certain genetics are sensitive to medications.  To learn more about Dr. Raszek and his work with Merogenomics, click here now! Episode also available on Apple Podcasts: http://apple.co/30PvU9

Welcome back to the new series of the Oxford Sparks Big Questions Podcast! We are here to answer weird and wonderful questions about our world, with the help of science. And we're starting with a very big question! How do you sequence the genomes of 70,000 species?   Dr Liam Crowley, from the Department of Biology, tells us about the ground-breaking Darwin Tree of Life project, which aims to sequence the genomes of over 70,000 species in Britain and Ireland. Discover the challenges and technological advances that make this monumental task possible, and explore the potential applications in fields like conservation genetics and evolutionary biology.   Tune in to find out how this project could revolutionise our understanding of biodiversity and the future of life on Earth!

In this podcast, hosts delve right into an enlightening discussion with Dr. Michael Charness, Dr. Kalpana Gupta, and Dr. Katherine Linsenmeyer about transmission dynamics in infection control. They particularly zero in on an investigation into the aerosol transmission of SARS-CoV-2 hours after hospital room changeovers, touching on key findings such as the significance of reversion mutations. They underline the key takeaways from this genomic epidemiology study and its implications for infection prevention. With special guests: Michael E. Charness, MD, Chief of Staff, VA Boston Healthcare System Kalpana Gupta, MD, MPH, Associate Chief of Staff and Chief of Infectious Disease, VA Boston Healthcare System Katherine Linsenmeyer, MD, Hospital Epidemiologist, VA Boston Healthcare System

For people in rural communities, access to genomic testing can require getting on a waitlist, delays in clinical assessment, and multiple visits to urban medical centers. A pilot study from Children's Mercy Research Institute in Kansas City, Missouri, found that by partnering with a rural clinic in a direct-to-provider model it was able to more than double the historic rate for rare disease diagnosis among the rural population and also cut the time-to-diagnosis by about five months. We spoke to Ana Cohen, assistant director of molecular genetics at CMRI, about its direct-to-provider model, how providing local support to patients at their regular clinics allowed them to bypass bottlenecks, and how the approach can shorten the time to a diagnosis for people with rare diseases in rural communities.

 Robert Green is a professor of genetics at Harvard Medical School. He's the director of Genetics Research at Brigham and Women's hospital and the co-founder of Nurture Genomics, where they're doing genomic screening for infants to detect and mitigate actionable genetic conditions. If you don't understand what that means, you're in the right place because we have a long conversation, digging into that topic and picking it apart for your understanding. This is a super exciting frontier for medicine. We are at a point where we know the science, and we know how to sequence a genome. We know how to correlate some of those things that we see in the genetic code to actual health problems that are predictive. Some of this is just a bug in the code that causes you to get some kind of cancer or other degenerative disease. We know it's there and in a lot of cases, we actually know what to do about it. There is no systematic screening for people, much less for infants. That's what Robert's trying to solve. This is very important, very exciting stuff and It will change the future of how we take care of people and prevent genetic diseases from disrupting their lives and taking their lives. You want to know about this. This is a great conversation. He's very good at explaining what's been found in the science and how they're implementing it. Enjoy! Important Links: G2P Nurture Genomics Harvard Medical School Brigham and Women's Hospital About Robert Green Robert C. Green, MD, MPH is a medical geneticist and physician-scientist who directs the G2P Research Program in translational genomics and health outcomes in the Division of Genetics at Brigham and Women's Hospital and Harvard Medical School. Dr. Green is currently Associate Director for Research of the Partners Center for Personalized Genetic Medicine, a Board Member of the Council for Responsible Genetics and a member of the Informed Cohort Oversight Boards for both the Children's Hospital Boston Gene Partnership Program and the Coriell Personalized Medicine Collaborative. He was the lead author of the recently published recommendations from the American College of Medical Genetics and Genomics for management of incidental findings in clinical sequencing.

Genome Sequencing for Kids – Robert Green

This podcast episode dives into the screening and management of Duchenne muscular dystrophy, as well as diversity in genetic databases, and treating neuromuscular disorders. Jonathan is joined by Madhuri Hegde, Senior Vice-President & Chief Scientific Officer at Revvity, Inc., to talk about innovation in genomic testing. Use the following timestamps to navigate our episode!   (00:00)-Introduction  (03:54)-Entering into genomic technologies (05:13)-Duchenne muscular dystrophy (10:47)-Revvity and genome sequencing (13:13)-Ultrarapid genomic testing (urWGS) (15:18)-LANTERN project (17:42)-Lack of diversity in genetic databases (20:06)-New developments in genetics (22:19)-COVID-19 testing laboratories (27:27)-Madhuri's wishes for healthcare

In this episode of ATP, Shambhavi Naik and Saurabh Todi discuss the recent completion of the 10,000 Genome Project and the importance of collecting such data for medical research. Do check out Takshashila's public policy courses: https://school.takshashila.org.in/courses We are @‌IVMPodcasts on Facebook, Twitter, & Instagram. https://twitter.com/IVMPodcasts https://www.instagram.com/ivmpodcasts/?hl=en https://www.facebook.com/ivmpodcasts/ You can check out our website at https://shows.ivmpodcasts.com/featured Follow the show across platforms: Spotify, Google Podcasts, Apple Podcasts, JioSaavn, Gaana, Amazon Music .Do share the word with your folks  See omnystudio.com/listener for privacy information.

In this episode, we connect with Dr. Mikolaj Raszek, the Founder and Managing Director of Merogenomics. As a consistent scientific thinker, Dr. Raszek is an expert in the field of genome sequencing. In 2014, he decided to start a business centering around this fascinating technology and hasn't looked back since…  The purpose of Merogenomics is to provide the general public with access to medical DNA testing. The results of these tests enable individuals to seek proper medical intervention for an array of conditions – all while giving them an inside look at their inner biology.  Join the discussion now to explore: The four groups that individuals fall into.  The medical value that DNA tests can provide.  What genome sequencing shows about the metabolization of medicine.  Why certain genetics are sensitive to medications.  To learn more about Dr. Raszek and his work with Merogenomics, click here now! Take advantage of a 5% discount on Ekster accessories by using the code FINDINGGENIUS. Enhance your style and functionality with premium accessories. Visit bit.ly/3uiVX9R to explore latest collection. Episode also available on Apple Podcasts: http://apple.co/30PvU9

Discover the groundbreaking research behind Dr. Schnable's Corn Genome Project and delve into the fascinating world of corn genetics.

CENTOGENE's Prof. Peter Bauer and Dr. Jorge Pinto Basto join host Ben Legg to look back on 25 Years since the human genome project was concluded. Today, we are discussing the Human Genome Project – looking at the initial impact, the advancements in the past 20 years, and what the future of genetics and rare disease patient care could look like. Before joining CENTOGENE, Jorge served as the Director of the Molecular Diagnostics and Genomics Labs at CGC Genetics. He holds a medical degree from the University of Porto and is specialized in Rare Disease Genetics, Neurogenetics, Dysmorphology, and Molecular Genetics. Listen in as Dr. Basto and Prof. Bauer share their insights into their journey with genomic testing 25 years later.

Guest: Dr. Bruce Y Lee, Executive Director of PHICOR (Public Health Informatics, Computational, and Operations Research) [@PHICORteam]On LinkedIn | https://www.linkedin.com/in/bruce-y-lee-68a6834/On Twitter | https://twitter.com/bruce_y_leeWebsite | https://www.bruceylee.com/On Forbes | https://www.forbes.com/sites/brucelee/On Psychology Today | https://www.psychologytoday.com/us/contributors/bruce-y-lee-md-mba_____________________________Host: Marco Ciappelli, Co-Founder at ITSPmagazine [@ITSPmagazine] and Host of Redefining Society PodcastOn ITSPmagazine | https://www.itspmagazine.com/itspmagazine-podcast-radio-hosts/marco-ciappelli_____________________________This Episode's SponsorsBlackCloak

In this episode of the Ramos Law Difference Makers podcast, we welcome back Ramos Law Director of Medical Sciences, Dr. Don Cooper, as he takes us on a journey through the world of genetics and genome sequencing. Dr. Cooper discusses cutting-edge medical advancements, focusing on the dynamic field of personalized medicine and the groundbreaking concept of polygenic risk scores. Exploring the realm of whole genome sequencing, he unveils the pivotal role it plays in identifying these intricate genetic variants, He sheds light on how this groundbreaking science has the power to transform medical diagnosis and treatment, as well as the ethical considerations of this science. Dr. Cooper also dives into whole genome sequencing as it relates to vaccine injuries, a type of legal case the team at Ramos Law represents, and its role in unveiling the probability and risk of injury. Join us on this journey of scientific discovery and ethical exploration on the Ramos Law Difference Makers Podcast! Learn more about Dr. Cooper and Ramos Law's Medical Sciences Division ⬇️ https://www.ramoslaw.com/our-team/experts/dr-donald-cooper/

Join us on the Newborn Screening SPOTlight podcast with Dr. Jerry Vockley, who is a Professor of Human Genetics, the Graduate School of Public Health, Cleveland Family Endowed Pediatric Research, School of Medicine, Chief of Genetic and Genomic Medicine, UPMC Children's Hospital of Pittsburgh, and Director of the Center for Rare Disease Therapy, UPMC Children's Hospital of Pittsburgh.    Dr. Vockley is internationally recognized as a leader in the field of inborn errors of metabolism. His current research focuses on mitochondrial energy metabolism, novel therapies for disorders of fatty acid oxidation and amino acid metabolism, and population genetics of the Plain communities in the United States. He has published over 320 peer-reviewed scholarly articles and is the principal or Co-investigator on multiple NIH grants. Dr. has an active clinical research program and participates in and consults on multiple gene therapy trials.   Dr. Vockley has served on numerous national and international scientific boards including the Advisory Committee (to the Secretary of Health and Human Services) on Heritable Disorders in Newborns and Children where he was chair of the technology committee. He is a Fellow in the American Association for the Advancement of Science. He is a Founding Fellow of the American College of Medical Genetics and Genomics, and currently serves on its board of directors. He is founder and chair of the International Network on Fatty Acid Oxidation Research and Therapy (INFORM). He has served as chair of the Pennsylvania State Newborn Screening Advisory Committee and is a past president of the International Organizing Committee for the International Congress on Inborn Errors of Metabolism and the Society for the Inherited Metabolic Disorders (SIMD). On this podcast, Dr. Vockley shares his career journey and personal stories about the impact of newborn screening research on physicians, families, and advocates.  Interview Questions: Among your many appointments, you serve on the Board of the American College of Medical Genetics and Genomics (ACMG) and advise on efforts to improve health through the practice of medical genetics and genomics. In addition to the ACMG board, you were integral in the early and current days of the NBSTRN. Can you tell us how you got involved in NBSTRN? As technologies to screen, diagnose, treat, and manage disease advance and increasingly use sequencing, can you share with our listeners your vision of how sequencing will be used in newborn screening in the future? What excites you about this potential, and can you share any concerns? You have published over 320 peer-reviewed scholarly articles and led many efforts funded by NIH and others. Can you describe the key findings from your most recent publication, “Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder.” You are the Cleveland Family Endowed Pediatric Research, School of Medicine Professor of Human Genetics, Graduate School of Public Health, and the Director of the Center for Rare Disease Therapy, UPMC Children's Hospital of Pittsburgh. In your article titled “Scaling genetic resources: New paradigms for diagnosis and treatment of rare genetic disease,” you mentioned that the movement from the basic science laboratory to clinical trials is still hampered by a regulatory system rooted in traditional trial design and requires a fresh assessment of safe ways to obtain approval for new drugs. You proposed the development and scaling of nucleic acid-based therapies. Could you share this possibility with our listeners and what challenges need to be overcome to deliver them safely with appropriate evaluation and long-term follow-up? Can you share any stories of inspiration that keep you going? Anything else you'd like to share? Thank you for your efforts in conceptualizing the NBSTRN and establishing a network of stakeholders that includes health professionals, researchers, state programs and families, and advocates. Do you have advice for this community and how they can help to realize and capitalize on the fifteen years of NBSTRN? You are involved in training the new generation of medical geneticists. What do you tell them about newborn screening research? What does NBS research mean to you?  

Guest: Dr. Bruce Y Lee, Executive Director of PHICOR (Public Health Informatics, Computational, and Operations Research) [@PHICORteam]On LinkedIn | https://www.linkedin.com/in/bruce-y-lee-68a6834/On Twitter | https://twitter.com/bruce_y_leeWebsite | https://www.bruceylee.com/On Forbes | https://www.forbes.com/sites/brucelee/On Psychology Today | https://www.psychologytoday.com/us/contributors/bruce-y-lee-md-mba_____________________________Host: Marco Ciappelli, Co-Founder at ITSPmagazine [@ITSPmagazine] and Host of Redefining Society PodcastOn ITSPmagazine | https://www.itspmagazine.com/itspmagazine-podcast-radio-hosts/marco-ciappelli_____________________________This Episode's SponsorsBlackCloak

In this episode of the G Word, Helen Webb, Product Lead for the bioinformatics pipeline at Genomics England, is joined by Dr Prabs Arumugam, Director of Clinical Data and Imaging and Caldicott Guardian for Genomics England and Kirsty Russell, Product Manager for cancer long-read sequencing at Genomics England, as they speak to Lizzie Mordey, a clinical trials coordinator, whose husband Stevie sadly passed away last year after receiving a sarcoma diagnosis. On average, 15 people in the UK are diagnosed with sarcoma cancer every day, but awareness of its signs and symptoms remains low. When Stevie first became unwell, after months of inconclusive tests, it was not until he had whole genome sequencing, that Stevie finally had some answers and received a diagnosis of sarcoma. July is Sarcoma Awareness Month, and in today's podcast, Lizzie takes us through Stevie's journey and how whole genome sequencing can provide answers and guide treatment decisions for patients diagnosed with sarcoma.   You can read the transcript here: Sarcoma-awareness-month-transcript.docx   If you'd like some further help or support after listening to this podcast, Sarcoma UK is a national charity that funds vital research, offers support for anyone affected by sarcoma cancer and campaigns for better treatments. The free Sarcoma UK Support Line is here for every person affected by sarcoma. You can call the confidential Sarcoma UK Support Line on 0808 801 0401 or email supportline@sarcoma.org.uk,or text 07860 058830 to speak with a specialist adviser.  

Make sure to grab Dr. Vincent Pedre's New Book!  In this episode, you will learn:  How to get into medication when you feel like you never have time. How to rewire if you are really stressed and amped up Why breath work through your nose is essential for proper oxygen Why eating and while stressed or while multitasking will not work for gut health Why we can't HEAL in a ramped up stressed state Why healing from a ZEN state is non negotiable So much disease is connected to the GUT b/c of leaky gut Why we get YEAST infections How do you know what is happening with your gut “The gut smart quiz” Why a STOOL or GI mapping test may not be necessary How common are parasites and why are they so hard to diagnose? Why STOOL PCR with Genome Sequencing is the only way to rule out a parasite Dr. Vincent M. Pedre, Medical Director of Pedre Integrative Health and President of Dr. Pedre Wellness, is a Board-Certified Internist in private practice in New York City since 2004. His philosophy and practices are a blend of both Western and Eastern medical traditions. He is a Clinical Instructor in Medicine at the Mount Sinai School of Medicine, as well as certified in yoga and Medical Acupuncture. His unique combination of medicine is best described as integrative or defined by a functional, systems-based approach to health. With his holistic understanding of both sides of the equation, he can help each patient choose the best course of action for their ailments to provide both immediate and long-term relief. His holistic approach incorporates positive, preventative health and wellness lifestyle choices. Dr. Pedre Wellness is a growing wellness platform offering health-enhancing programs, along with informative social media and lifestyle products, such as dietary supplements, books and weight loss programs.  

Show is Sponsored by Ayn Rand University https://university.aynrand.org/ as well as by https://www.expressvpn.com/yaron & https://www.fountainheadcasts.comJoin this channel to get access to perks:https://www.youtube.com/@YaronBrook/joinLike what you hear? Like, share, and subscribe to stay updated on new videos and help promote the Yaron Brook Show: https://bit.ly/3ztPxTxSupport the Show and become a sponsor: https://www.patreon.com/YaronBrookShowOr make a one-time donation: https://bit.ly/2RZOyJJContinue the discussion by following Yaron on Twitter (https://bit.ly/3iMGl6z) and Facebook (https://bit.ly/3vvWDDC )Want to learn more about Ayn Rand and Objectivism? Visit the Ayn Rand Institute: https://bit.ly/35qoEC3​#China #chinaprotest #ukrainewar #russiaukrainewar #genomesequencing #capitalism #Economy ​#Objectivism​ #AynRand #politics

There's a quiet revolution happening in the field of genetic screening of newborns. Within the last couple of years it's become possible to sequence the entire genome of a newborn baby, all six billion base pairs of DNA, and diagnose potential genetic disorders in about 7 hours. That's already happening in a handful of hospitals, with a focus on babies who are showing symptoms of rare genetic disorders. But within five years, says Harry's guest, Dr. Stephen Kingsmore, it should be possible to extend this rapid whole-genome sequencing to every baby in every hospital, whether they're showing symptoms or not.Kingsmore earned his medical degrees in Northern Ireland, trained in internal medicine and rheumatology at Duke, and studied genomic medicine at Children's Mercy Hospital in Kansas City. And he's now the president and CEO of the Institute for Genomic Medicine at Rady Children's Hospital in San Diego. There, he's been leading an aggressive push to prove that rapid whole-genome sequencing and diagnosis can not only save the lives of newborns, but save the healthcare system a lot of money by making hospital stays shorter and therapies more directed. He's been able to use that argument to get Medicaid agencies in California and five other states, as well as a handful of private insurance companies, to cover whole-genome sequencing as the new standard of care for babies who end up in intensive care with unexplained illnesses. And if his newest project, BeginNGS, succeeds, it could lead to universal screening of all newborns for hundreds or even thousands of rare genetic disorders. For a full transcript of this episode, please visit our episode page at http://www.glorikian.com/podcast Please rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac. 2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings & Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars. 6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner. 8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out. 9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.

Welcome to Episode 11 of the BioHackers Podcast!In this episode, David and Alex welcome famed plant geneticist Alex Harkess from HudsonAlpha Biotechnology Institute. Together, they discuss genomic time traveling, cloning trees, the bridge from education to research, biohacking, and the power of telling stories for organisms that can't speak for themselves.  Watch the Video Podcast on YouTube: https://youtu.be/KqFdb4pbVlIHere is a list of topics: Welcome to Episode 11 (00:00)Ethnobotany and Childhood Trees (01:07)Welcome Alex to the Show (06:56)Alex's Story and Love of Trees (07:28)The Magic of Diversity (13:24)How Did the World Work Together with Hudson Alpha? (16:04)Genome Sequencing is Time Traveling (20:26)How Do Trees Capture Your Imagination? (26:32)Expanding the Harkess Lab Digitally (28:23)Overcoming the Inequity of the Field of Science (30:53)Cloning the Iconic Auburn Oaks (39:15)Unleashing Creativity with Online Learning (44:15)Democratizing Course Creation (47:52)Sharing and Caring in Genomics Academics (51:45)What is the Difference Between Research and Education? (56:00)What is a BioHacker to You? (59:40)Closing Thoughts (01:01:15)Enjoy the Show!

Genome sequencing has become a household term during this pandemic. This week, we explore how it became an important tool in the fight against Covid-19.

Genome sequencing was New Zealand's superpower during the early days of the Covid-19 pandemic. Our Changing World gets the inside story of our remarkable use of this tech, and what it revealed about the SARS-CoV-2 virus.

For the 100th episode of The Harry Glorikian Show, Harry welcomes Phil Febbo, chief medical officer at Illumina. The San Diego-based company is the leading maker of the high-speed gene sequencing machines that are at the core of the precision medicine revolution. The company has an 80 percent market share, which means that if you or your loved one has had any sequencing done for any reason, chances are your samples were sequenced on an Illumina machine. Gene sequencing is already a key part of both diagnostics and treatment decisions for many disease, but its use is only going to expand as the technology gets faster and cheaper.This fall, Illumina announced that it's coming out a new gene sequencing machine called the NovaSeq X that can sequence a genome more than twice as fast as Illumina's previous top-of-the-line machine, and at a lower cost. That's bound to speed up progress all across the field of genetic medicine, drug discovery, and life science research. And that's where Harry starts his interview with Febbo.For a full transcript of this episode, please visit our episode page at http://www.glorikian.com/podcast Please rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac. 2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings & Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars. 6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner. 8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out. 9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.

Illumina just announced a machine that can crack genomes twice as fast as its current version—and drive the cost down to $200 a pop.

Illumina just announced a machine that can crack genomes twice as fast as its current version—and drive the cost down to $200 a pop.

In this episode: We are back talking with Mike Hu about Project GUARDIAN. Project GUARDIAN advocates for and supports sequencing based newborn screening to identify pre-symptomatic patients who can either benefit from early intervention using existing treatments or eligible for clinical trials of novel treatments, at a disease stage when treatment could be maximally efficacious. We discuss what genome sequencing is and the role it can play in diagnosis of rare diseases in the future. We also discussed epigenetic modifications that are specific to an individual. How is genomic sequencing different than mass spectrometry and how could it transform newborn screening? Mike unpacks his vision. When we talk about expansion of the newborn screening system, it is necessary to introduce new platforms that go beyond mass spectrometry, and genomic sequencing is a suitable one. We discuss the challenges introducing large scale sequence based newborn screening studies in the US.  The  National MPS Society exists to cure, support, and advocate for MPS and ML.If you like Our Voices, visit our website and follow us on social media on Facebook, Instagram, Twitter, and LinkedIn. And if you like the podcast, we'd appreciate you telling a friend (maybe even two).      

In this episode, recorded in the cloud forests of Oaxaca, we discuss the entheome project, which centers around genome sequencing of entheogens as well as many of their sympatric species of fungi, plants and microbes that also grow in the ecosystems these entheogens are native to. We talk about democratizing science and DNA sequencing, and we talk about what some practical applications of this science are and how to make it accessible to people who DON'T want to take out 150 grand in student loans in order to learn it.

On this ID the Future from the vault, philosopher of science Paul Nelson concludes his talk with host Andrew McDiarmid on what it takes to converse effectively with scientists who are trapped in a naturalistic parabola — that is, researchers who draw their conclusions from naturalism's authority rather than following the evidence wherever it leads. Nelson urges us to keep the third party in the conversation: nature herself. We listen to nature through experiment, he says, and warns against the message from scientists such as CalTech's Sean Carroll who have suggested that testing is “overrated.” If we listen and test, nature can keep revealing herself in surprising ways, says Nelson, which is what makes science so fun. Source

Genome sequencing is one of the most exciting scientific breakthroughs of the past thirty years. But what precisely does it involve and how is it developing? In Genomics: How Genome Sequencing Will Change Healthcare (Random House, 2022), Rachael Pells explains the science behind genomics. She analyses its practical applications in medical diagnosis and the treatment of conditions that range from cancer to severe allergic reactions to cystic fibrosis. She considers its potential to help with advances in agriculture and environmental science. She explores the ethics of genetic modification and the dangers involved when humans 'play God'. And she addresses the fundamental question: to what extent will future advances transform human longevity and the quality of life. Galina Limorenko is a doctoral candidate in Neuroscience with a focus on biochemistry and molecular biology of neurodegenerative diseases at EPFL in Switzerland. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Genome sequencing is one of the most exciting scientific breakthroughs of the past thirty years. But what precisely does it involve and how is it developing? In Genomics: How Genome Sequencing Will Change Healthcare (Random House, 2022), Rachael Pells explains the science behind genomics. She analyses its practical applications in medical diagnosis and the treatment of conditions that range from cancer to severe allergic reactions to cystic fibrosis. She considers its potential to help with advances in agriculture and environmental science. She explores the ethics of genetic modification and the dangers involved when humans 'play God'. And she addresses the fundamental question: to what extent will future advances transform human longevity and the quality of life. Galina Limorenko is a doctoral candidate in Neuroscience with a focus on biochemistry and molecular biology of neurodegenerative diseases at EPFL in Switzerland. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

Genome sequencing is one of the most exciting scientific breakthroughs of the past thirty years. But what precisely does it involve and how is it developing? In Genomics: How Genome Sequencing Will Change Healthcare (Random House, 2022), Rachael Pells explains the science behind genomics. She analyses its practical applications in medical diagnosis and the treatment of conditions that range from cancer to severe allergic reactions to cystic fibrosis. She considers its potential to help with advances in agriculture and environmental science. She explores the ethics of genetic modification and the dangers involved when humans 'play God'. And she addresses the fundamental question: to what extent will future advances transform human longevity and the quality of life. Galina Limorenko is a doctoral candidate in Neuroscience with a focus on biochemistry and molecular biology of neurodegenerative diseases at EPFL in Switzerland. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science

Genome sequencing is one of the most exciting scientific breakthroughs of the past thirty years. But what precisely does it involve and how is it developing? In Genomics: How Genome Sequencing Will Change Healthcare (Random House, 2022), Rachael Pells explains the science behind genomics. She analyses its practical applications in medical diagnosis and the treatment of conditions that range from cancer to severe allergic reactions to cystic fibrosis. She considers its potential to help with advances in agriculture and environmental science. She explores the ethics of genetic modification and the dangers involved when humans 'play God'. And she addresses the fundamental question: to what extent will future advances transform human longevity and the quality of life. Galina Limorenko is a doctoral candidate in Neuroscience with a focus on biochemistry and molecular biology of neurodegenerative diseases at EPFL in Switzerland. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society

The Galapagos Islands are famous for their tortoises, among many other things. A few million years ago, some giant tortoises from South America were somehow carried across hundreds of miles of ocean to the islands – perhaps on driftwood during storms.  Tortoises don't swim, so any that made to an island could only breed with […]

Imagine trying to put together a puzzle with over 900 million pieces without the picture on the box... That's how PhD candidate Stephanie Chen describes her world-first research assembling the complete genome of the iconic waratah species.

What is genome sequencing and how does it help us track diseases? Why do countries need to continue genome sequencing in this phase of the pandemic? WHO's Chief Scientist Dr Soumya Swaminathan explains in Science in 5 . 

Tahmima Anam is an anthropologist and a novelist. She's a big fan of silence and believes it can been harnessed to challenge sexism and expose bad behaviour. We talk about the pros, cons and ethics of genome sequencing for new-borns. A new pilot will be running shortly, so we speak to Vivienne Parry, Head of Engagement at Genomics England and Rebecca Middleton, who has an inherited brain aneurysm disorder and is a member of the panel representing parents and health care professionals. Do you know what "fexting" is? Do you do it? It's in the headlines because the First Lady of the United States, Jill Biden, has admitted that she 'fexts' with her husband. It means fights over text. So we're asking is it a good way to row? Behavioural psychologist and relationship coach, Jo Hemmings helps us out.  In Japan abortion pills are illegal, but that's due to change by the end of the year. However it looks like a woman who's in a relationship will need permission from her male partner before she gets them, plus the cost could be out of reach for many. We speak to women rights campaigner, Kazuko Fukuda, and the BBC's Mariko Oi in Tokyo. And we've got Twinnie, the singer and songwriter from York. She describes her music as country pop, and her new track is called Welcome To The Club.

Two bombshells that show the depth of corruption at the CDC and NIH. Fauci is as bad as his worst accusers ever said. Watch the video to find out for yourself. DISCLAIMER: Views and opinions expressed on The Ben Armstrong Show are solely those of the host and do not necessarily represent those of The ... The post Fauci/NIH Secretly Paid $350 Million In Royalties and Removed COVID19 Genome Sequencing Records appeared first on The New American.

Lauren Dunn reports on the effort to resettle Afghan and Ukrainian refugees in the United States; Leigh Jones reports on the push to reform the U.S. Bureau of Prisons; and Paul Butler reports on the finished human genome map. Plus: commentary from Steve West, antisocial behavior, and the Tuesday morning news.Support The World and Everything in It today at wng.org/donate. Additional support comes from Crossway, publisher of the English Standard Version Bible—helping you read and engage with God's Word. ESV.orgAnd from Heart of Dakota, providing Christ-centered, literature-based homeschool curriculum. Featuring open-and-go daily plans, engaging books, and fun activities with God's Word at the heart, our award-winning curriculum will take you all the way from preschool through high school. With Heart of Dakota, you'll love learning again! More at heartofdakota.com.Emmaus Bible College prepares students to impact the world for Christ. In addition to Bible and Theology, we offer a broad range of high demand academic programs, including Computer Science, Business, Teacher Education, and many more. Find Christ-centered education, uncompromised biblical teaching, and valuable professional degrees in a college community that encourages your spiritual growth. Learn more at emmaus.edu.

Welcome to Conversations on Sol Luckman Uncensored, sponsored by Snooze2Awaken.com, Resources for Lucidity. For more information about my work, including a lot of fantastic free content, check out www.CrowRising.com. I'm also now on Telegram, where I'm sharing daily truth bombs at https://t.me/solluckman … Today, for the first time on the show, I have the privilege of interviewing one of the most salient COVID debunkers in the entire blogosphere: Mike Stone. I urge you to spend some quality time with his extraordinary work at https://viroliegy.com. Owing to his keen insight and gift as a writer, Mike has exploded onto the radar among the community of skeptics of not just the official but even most alternative COVID narratives, having been referenced by the likes of Dr. Tom Cowan and Dr. Sam Bailey. I've reblogged several of Mike's articles, including: The Case against “Viral” Genomes https://snooze2awaken.com/2022/03/14/the-case-against-viral-genomes Documenting the “Virus” Lie https://snooze2awaken.com/2022/02/28/documenting-the-virus-lie and The Challenges Related to RNA Extraction for Genome Sequencing https://snooze2awaken.com/2022/02/08/the-challenges-related-to-rna-extraction-for-genome-sequencing This isn't light reading, folks, but it's ESSENTIAL reading for anyone interested in knowing the TRUTH about the LIES of virology. By way of further introduction, in Mike's own words: "I am not a doctor, virologist, microbiologist, scientist, etc. Many will use this against me. My educational background is in Health and Exercise Science. I have been a personal trainer, a nutritionist, and currently I am a health/wellness coach. What I share here is based upon years of research and reading from the original studies/sources." Additional Show Links: Benjamin Fulford's Latest Drivel … https://www.rumormillnews.com/cgi-bin/forum.cgi?read=195215 Current Variant Scam https://www.nytimes.com/2022/03/11/science/deltacron-coronavirus-variant.html China Doing What China Does https://news.yahoo.com/covid-finally-spins-control-china-130734740.htm Gain of Function Garbage https://snooze2awaken.com/2022/02/10/dr-sam-bailey-gain-of-function-garbage

Modern technology can be one of our most powerful allies to heal and to radiant health. In this episode I speak to Dr. Michael Snyder about the current state and the future of wearable technology and big data and how it shapes personalized medicine. Dr. Michael Snyder is the chairman of the Department of Genetics and the director of the Center for Genomics and Personalized Medicine at Stanford University. Wearable electronic devices can help consumers and patients monitor their health, sleep, fitness, mood and even alert to the presence of an infection. Additionally wearables can share information with the user's physician, enabling the wearer to monitor and maintain health in real time. Dr. Snyder himself uses eight wearables and refers to himself as one of the most extensively monitored scientific researchers. When it comes to data, he is an advocate for "more is better" and today he will share with us why. In this episode, you'll learn: -A day in the life at Snyder lab on Stanford University campus...02:15 -Using genome sequencing to prevent disease risk...04:35 -How technology can save lives through early identification...07:30 -Glucose monitors as a means to know what foods spike glucose...10:15 -Big biometric data, wearables data, and privacy concerns...13:45 -Benefits of data outweigh risks: detection before symptoms...18:00 -Every decision about your health is based on population based measurements ...21:00 -Dr. Snyder explains the eight wearable devices he wears daily...23:50 -Aging molecular type: how are YOU aging?...25:25 -Predictions for personalized medicine and the role of wearables...28:45 -Health care will focus on differentiation from individualized baselines...32:30 -The economic factor of extended life span and extended health span...36:10 -Ageism in our youth focused culture...38:35 -The need for creative ways to transform American 'sick care' to a true health care system...40:30 -The personal practice that Dr. Snyder swears by...44:40 Resources mentioned: https://med.stanford.edu/snyderlab/about.html (Dr. Snyder's website) https://www.amazon.com/Genomics-Personalized-Medicine-Everyone-Needs/dp/0190234768/ (Dr. Snyder's book, Genomics and Personalized Medicine: What everyone needs to know)

Claudia brings us cold cases that were solved in 2021! 2021 may not have been the best year for most of us, but in the cold case world it has been an amazing year if you ask us!  Claudia talks about 4 cases that went cold for nearly 50 years and how Genome Sequencing helped bring closure to the victims families Support the show

In this episode hosts Astra, Fel, and Han explore ancestry, the importance of DNA in determining eligibility to participate in closed practices and other traditions alongside issues of biological essentialism. Do DNA tests such as 23 & Me actually give you accurate and useable data? If so, how, if at all, does that translate to occult practices? Or is a practice defined by the spirituality of location and not through biological inheritance?Want to discuss these topics with us more? Join the discord here: https://discord.gg/kJthJyxTBcResources:Low Coverage of Whole Genome Sequencing: https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-019-0682-2History and Current Approaches to Genome Sequencing: https://reader.elsevier.com/reader/sd/pii/S2001037019303277?token=E13A38288C654F65E0304EA37B1108BF2348D197EC9AC225338DCF7E210A65FC87FC4D1588C854C5FD51884F7DFE04E1&originRegion=us-east-1&originCreation=20211120003753Personalised Medicine and Whole Genome Sequencing: https://www.frontiersin.org/articles/10.3389/fgene.2019.00049/fullAncestry: Understanding Genetics (good summary of science in English terms): https://genetics.thetech.org/ask-a-geneticist/same-dna-different-ancestry-resultsDefining signal thresholds in DNA microarrays: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC117791/Black Death Left a Mark on the Human Genome: https://www.science.org/content/article/black-death-left-mark-human-genome

Stephanie Marciniak, Logan Kistler, and Ed Louis describe an extinct giant lemur.